Botulinum toxin in neuro-urological disorders

Movement Disorders

Volumn 19, Issue SUPPL. 8, 2004, Pages

  Jost, Wolfgang H ^a   Naumann, Markus ^b  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Botulinum toxin; Detrusor; Hyperreflexia; Urology

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; ANTIPARKINSON AGENT;

ARTICLE; AUTONOMIC DYSREFLEXIA; BLADDER BLEEDING; BLADDER DISEASE; BLADDER PERFORATION; BLADDER SPHINCTER PROSTHESIS; CHRONIC PAIN; DETRUSOR DYSSYNERGIA; DISEASE EXACERBATION; DRUG COST; DRUG INDICATION; DRUG USE; HEMATOMA; HUMAN; HYPERREFLEXIA; INFECTION; MICTURITION DISORDER; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PARESIS; PELVIC DISEASE; PRIORITY JOURNAL; PROSTATE DISEASE; REPRODUCIBILITY; RESIDUAL URINE; SMOOTH MUSCLE SPASM; SPASTICITY; TREATMENT OUTCOME; URETHRA DISEASE; URETHRAL BLEEDING; URINARY TRACT DISEASE; URINE INCONTINENCE; VAGINISM; VALIDATION PROCESS; DRUG EFFECT; PATHOLOGICAL REFLEX; REVIEW; UROLOGY;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; HUMANS; REFLEX, ABNORMAL; TREATMENT OUTCOME; UROLOGIC DISEASES; UROLOGY;

EID: 3242798931     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20068     Document Type: Article

References (16)

1. Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988;139:912-922.
2. Dykstra DD, Sidi AA. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 1990;71:24-26.
3. Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996;155:1023-1029.
4. Petit H, Wiart L, Gaujard E, Le Breton F, Ferrière JM, Lagueny A, Joseph PA, Barat M. Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 1998;36: 91-94.
5. Jost WH. Treatment of detrusor sphincter dyssynergia with botulinum toxin. J Neurol 1999;246:I/89.
6. Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, Yoshimura N, Chancellor MB. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 2001;165:1107-1110.
7. Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum A toxin for treating detrusor hyperreflexia in spinal cord injured patients:a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000;164:692-697.
8. Grosse JO, Kramer G, Löchner-Ernst D, Stöhrer M. Outcome of repeat detrusor injections of botulinum A toxin (BTX-A) for severe neurogenic detrusor overactivity and incontinence. 98th Annual Meeting of the American Urological Association, April 26-May 1, 2003, Abstract 102067.
9. Schulte-Baukloh H, Michael T, Schobert J, Stolze T, Knispel HH. Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele. Urology 2002;59:325-327.
10. Jost WH, Merkle W, Müller-Lobeck H. Urethrismus accounting for voiding disorder. Urology 1998;52:352.
11. Jost WH, Ziegler M, Bewermeier H, Schimrigk K. Botulinum toxin in the treatment of insufficient neobladder emptying. Mov Disord 1995;10:404.
12. Smith CP, O'Leary M, Erickson J, Somogyi GT, Chancellor MB. Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation. Int Urogynecol J Pelvic Floor Dysfunct 2002;13:55-56.
13. Zermann D, Ishigooka M, Schubert J, Schmidt RA. Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 2000;38:393-399.
14. Doggweiler R, Zermann DH, Ishigooka M, Schmidt RA. Botox-induced prostatic involution. Prostate 1998;37:44-50.
15. Brin MF. Treatment of vaginismus with botulinum toxin injections. Lancet 1997;349:252-253.
16. Jost WH, Selbach O. Vaginismus - Therapie mit Botulinumtoxin A. Sexualmedizin 1998;4:37-49.